This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Cross Country (CCRN) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Cross Country (CCRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Cross Country Healthcare (CCRN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 137.50% and 12.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
What Awaits Cross Country Healthcare (CCRN) in Q4 Earnings?
by Zacks Equity Research
Cross Country Healthcare's (CCRN) fourth-quarter 2020 earnings are expected to have moved up year over year.
Cross Country Healthcare (CCRN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cross Country Healthcare (CCRN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed the most recent trading day at $9.64, moving -1.83% from the previous trading session.
Has Cross Country Healthcare (CCRN) Outpaced Other Business Services Stocks This Year?
by Zacks Equity Research
Is (CCRN) Outperforming Other Business Services Stocks This Year?
Reasons to Retain Envestnet (ENV) Stock in Your Portfolio
by Zacks Equity Research
Envestnet (ENV) continues to benefit from its solid recurring revenue generation capacity.
Huron Consulting (HURN) Announces Acquisition of Unico Solution
by Zacks Equity Research
The buyout is expected to boost Huron's (HURN) Informatica capabilities.
Reasons to Retain MAXIMUS (MMS) Stock in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) has a diversified portfolio with high operating profit margin, high cash conversion and access to a $400 million credit facility.
5 Reasons to Invest in FLEETCOR Technologies (FLT) Stock
by Zacks Equity Research
FLEETCOR's (FLT) acquisition moves help expand its customer base, headcount and operations, and diversify service offerings across industries.
Broadridge (BR) Announces Collaboration With Software Vender SLIB
by Zacks Equity Research
Broadridge's (BR) collaboration with SLIB is aimed at offering a cross-border proxy voting solution for compliance of Shareholder Rights Directive II (SRD II).
Why Cross Country (CCRN) Stock Might be a Great Pick
by Zacks Equity Research
Cross Country (CCRN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
New Strong Buy Stocks for December 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Buy 5 Top Stocks with Strong Earnings Beat Prospects
by Sanghamitra Saha
Invest in top-ranked stocks that are likely to beat earnings estimates in the upcoming releases.
New Strong Buy Stocks for December 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Cross Country (CCRN) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Cross Country (CCRN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for December 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Will Cross Country (CCRN) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Cross Country (CCRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
New Strong Buy Stocks for December 3rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Moving Average Crossover Alert: Cross Country Healthcare (CCRN)
by Zacks Equity Research
Cross Country Healthcare (CCRN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Zacks.com featured highlights include: ARCB, BG, AXL, CCRN and BZH
by Zacks Equity Research
Zacks.com featured highlights include: ARCB, BG, AXL, CCRN and BZH
Cross Country, Alkaline Water, Enphase Energy, Canadian Solar and TOTAL as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cross Country, Alkaline Water, Enphase Energy, Canadian Solar and TOTAL as Zacks Bull and Bear of the Day
Bull Of The Day: Cross Country Healthcare (CCRN)
by Brian Bolan
This medical staffing firm is going to benefit from the dramatic rise in healthcare salaries
5 Stocks to Keep an Eye on Following Upgrade by Brokers
by Maharathi Basu
Advice from brokers is desirable for designing a winning portfolio of stocks. One should watch out for broker-favorite bets like ArcBest (ARCB), Bunge Ltd. (BG), American Axle (AXL), Beazer Homes (BZH) and Cross Country Healthcare (CCRN).
3 Stocks to Benefit From the Steady Growth in Jobs
by Zacks Equity Research
Steadily rising U.S. jobs and falling unemployment make it judicious to invest in staffing firms like Insperity (NSP) and Cross Country Healthcare (CCRN).